Answers are grounded in this paper and cite their sources.
Review evaluates antiviral properties in herbal medicines for HIV, suggesting potential adjuncts to ART.
The global burden of HIV/AIDS persists, with millions still lacking access to antiretroviral therapy (ART). While ART has significantly improved life expectancy for people living with HIV (PLHIV), its limitations such as drug resistance, toxicity, and accessibility prompt the need for alternative or complementary approaches. Herbal medicines, traditionally used in many cultures for treating infectious diseases, are increasingly investigated for their potential antiviral activity against HIV. This paper reviews the antiviral properties of various medicinal plants and their extracts, focusing on their effectiveness in vitro and in vivo. Several herbs, including Calamus rotang, Codonopsis tubulosa, and Erigeron annuus, have demonstrated potential anti-HIV activity by inhibiting viral entry and replication. The study emphasizes the importance of evaluating safety, efficacy, and herb-drug interactions, especially in resource-limited settings where herbal remedies are widely used. Ethical and regulatory considerations are also explored to ensure safe integration of herbal therapies with standard HIV treatment. Ultimately, herbal medicines could offer affordable, accessible adjuncts to ART, warranting further clinical trials.
No takes yet. Share an insight, caveat, or question.
Chelimo Faith Rebecca (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: